Birin, Aisa .

HRN: 23-95-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
CEFTRIAXONE 1G (VIAL)
10/25/2023
11/01/2023
IV
2g
OD
Complicated UTI
Waiting Final Action 
10/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/27/2023
11/03/2023
IV
500
Q8
Complicated UTI
Waiting Final Action 
11/09/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/09/2023
11/15/2023
IV
2.25g
Q6
Complicated UTI
Waiting Final Action 
11/11/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/11/2023
11/15/2023
IV
2.5g
Q6
T/c Ascending Cholangitis
Waiting Final Action 
11/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/11/2023
11/17/2023
IV
500mg
Q8
T/c Ascending Cholangitis
Waiting Final Action 
11/16/2023
MUPIROCIN 2%, 15G (TUBE)
11/16/2023
11/22/2023
TOPICAL
2%
TID
Pressure Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: